Does VALSARTAN Cause Application site discolouration? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Application site discolouration have been filed in association with VALSARTAN (valsartan). This represents 0.0% of all adverse event reports for VALSARTAN.
5
Reports of Application site discolouration with VALSARTAN
0.0%
of all VALSARTAN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Application site discolouration From VALSARTAN?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Application site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Application site discolouration?
SUMATRIPTAN (684)
BUPRENORPHINE (208)
INGENOL MEBUTATE (115)
MECHLORETHAMINE (101)
ESTRADIOL (89)
NICOTINE (87)
MINOXIDIL (76)
SALICYLIC ACID (76)
BECAPLERMIN (74)
DICLOFENAC (67)
Which VALSARTAN Alternatives Have Lower Application site discolouration Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL